Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Amicus Therapeutics (FOLD) over the last 17 years, with Q3 2025 value amounting to 0.27.

  • Amicus Therapeutics' Equity Ratio rose 1665.53% to 0.27 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.27, marking a year-over-year increase of 1665.53%. This contributed to the annual value of 0.25 for FY2024, which is 2004.25% up from last year.
  • Per Amicus Therapeutics' latest filing, its Equity Ratio stood at 0.27 for Q3 2025, which was up 1665.53% from 0.25 recorded in Q2 2025.
  • Amicus Therapeutics' 5-year Equity Ratio high stood at 0.39 for Q3 2021, and its period low was 0.15 during Q1 2023.
  • Over the past 5 years, Amicus Therapeutics' median Equity Ratio value was 0.23 (recorded in 2024), while the average stood at 0.23.
  • Per our database at Business Quant, Amicus Therapeutics' Equity Ratio tumbled by 5566.61% in 2022 and then surged by 4171.93% in 2025.
  • Over the past 5 years, Amicus Therapeutics' Equity Ratio (Quarter) stood at 0.34 in 2021, then crashed by 49.96% to 0.17 in 2022, then grew by 21.18% to 0.21 in 2023, then grew by 20.04% to 0.25 in 2024, then increased by 7.3% to 0.27 in 2025.
  • Its last three reported values are 0.27 in Q3 2025, 0.25 for Q2 2025, and 0.25 during Q1 2025.